Feed Preview

Fast Growing

Microbiome Modulation in Parkinson's Disease

Microbiome Modulation in Parkinson's Disease diagram by Sakurra, Shutterstock
Sakurra, Shutterstock

The gut microbiota shares a symbiotic relationship with the human host. Dysbiosis is linked with several neurological pathologies including Parkinson’s disease (PD). Here is the latest research on the modulation of PD by the gut microbiota.

Top 20 most recent papers
135
1
The Journal of Headache and Pain

Gut-brain Axis and migraine headache: a comprehensive review

The Journal of Headache and PainFebruary 15, 2020
Mahsa ArzaniSchool of Advanced Studies of the European Headache Federation (EHF-SAS)
50
1
Digestive Diseases and Sciences

Abnormal Intestinal Microbiome in Medical Disorders and Potential Reversibility by Fecal Microbiota Transplantation

Digestive Diseases and SciencesFebruary 3, 2020
Herbert L DuPontNetanya S Utay
9
bioRxiv

Gut microbiome signatures of risk and prodromal markers of Parkinson’s disease

bioRxivDecember 12, 2019
Sebastian HeinzelFilip Scheperjans
16
Frontiers in Neuroendocrinology

You've Got Male: Sex and the Microbiota-Gut Brain Axis Across the Lifespan

Frontiers in NeuroendocrinologyDecember 6, 2019
Minal JaggarJohn F Cryan
75
1
4
Parkinsonism & Related Disorders

Gastrointestinal symptoms are predictive of trajectories of cognitive functioning in de novo Parkinson's disease

Parkinsonism & Related DisordersFebruary 15, 2020
Jacob D JonesJonathan P Jacobs
20
1
2
Frontiers in Neurology

Diet in Parkinson's Disease: Critical Role for the Microbiome

Frontiers in NeurologyJanuary 11, 2020
Aeja JacksonAli Keshavarzian
62
1
4
Lancet Neurology

The gut microbiome in neurological disorders

Lancet NeurologyNovember 23, 2019
John F CryanTimothy G Dinan
484
3
9
Nature Communications

Programmable meroterpene synthesis

Nature CommunicationsJanuary 26, 2020
Xingyu ShenThomas J Maimone
13
1
Frontiers in Microbiology

Brain Microbiota in Huntington's Disease Patients

Frontiers in MicrobiologyDecember 5, 2019
Ruth AlonsoLuis Carrasco
88
1
2
AIDS Research and Human Retroviruses

A summary of the fourth annual Virology Education HIV Microbiome workshop

AIDS Research and Human RetrovirusesJanuary 10, 2020
Brett WilliamsAlan Landay
3
Molecular Neurodegeneration

Synergistic effects of APOE and sex on the gut microbiome of young EFAD transgenic mice

Molecular NeurodegenerationDecember 22, 2019
Juan Maldonado WengMary Jo LaDu
2
1
Cellular and Molecular Neurobiology

Actions of Trace Amines in the Brain-Gut-Microbiome Axis via Trace Amine-Associated Receptor-1 (TAAR1)

Cellular and Molecular NeurobiologyDecember 15, 2019
Katlynn Bugda GwiltGregory M Miller
5
Translational Neurodegeneration

Microbiome changes: an indicator of Parkinson's disease?

Translational NeurodegenerationJanuary 1, 2020
Caroline HaikalJia-Yi Li
7
1

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/microbiome-modulation-in-parkinsons/f4f785f1-a735-4989-af87-13dc7e25ad75